Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Metadata
Title
Galanthamine in Alzheimer’s Disease
A New Alternative to Tacrine?
Author
Dr Michael Rainer
Publication date
01-02-1997
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 2/1997
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-199707020-00001

Other articles of this Issue 2/1997

CNS Drugs 2/1997 Go to the issue

Adis New Drug Profile

Levetiracetam

Review Articles

Polydipsia-Hyponatraemia Syndrome

Review Articles

Mechanism of Clozapine-Induced Agranulocytosis

Disease Management

Subacute Sclerosing Panencephalitis

Disease Management

Trigeminal Neuralgia

Guest Commentaries

Levetiracetam